Literature DB >> 25608841

Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer.

Zhengjun Yang1, Bin Zhang, Bowen Liu, Yegong Xie, Xuchen Cao.   

Abstract

The purpose of this study was to investigate the prognostic value of Runx2 and Snail expression in breast cancer. The expression of Runx2 and Snail in clinical specimens from 125 breast cancer patients was detected by immunohistochemistry. The results showed there is a link between Runx2 and Snail expression at protein levels (p = 0.007). The Kaplan-Meier survival analysis showed that Runx2 or Snail expression was correlated with shortened disease-free survival (DFS) (p = 0.002, p = 0.004, respectively) and overall survival (OS) (p = 0.002, p = 0.009, respectively). In addition, Runx2-positive/Snail-positive patients had the worst DFS and OS (p = 0.001, p < 0.001, respectively). In multivariate survival analysis, Runx2, Snail, and combined Runx2/Snail were still remained as independent prognostic factors for DFS (p = 0.020, p = 0.013, and p = 0.001, respectively) and OS (p = 0.027, p = 0.030 and p = 0.005, respectively). These results suggest that a combined Runx2/Snail expression could be used as a new significant prognostic biomarker for patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25608841     DOI: 10.1007/s13277-015-3101-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway.

Authors:  Ya-Ling Hsu; Ming-Shyan Huang; Chih-Jen Yang; Jen-Yu Hung; Ling-Yu Wu; Po-Lin Kuo
Journal:  J Biol Chem       Date:  2011-09-01       Impact factor: 5.157

3.  The transcription factor snail regulates osteogenic differentiation by repressing Runx2 expression.

Authors:  Su Jin Park; Seung-Hyun Jung; Gadi Jogeswar; Hyun-Mo Ryoo; Jong In Yook; Han Seok Choi; Yumie Rhee; Cheol-Hee Kim; Sung-Kil Lim
Journal:  Bone       Date:  2010-03-07       Impact factor: 4.398

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor.

Authors:  Tomohiko Sase; Takashi Suzuki; Koh Miura; Kenichi Shiiba; Ikuro Sato; Yasuhiro Nakamura; Kiyoshi Takagi; Yoshiaki Onodera; Yasuhiro Miki; Mika Watanabe; Kazuyuki Ishida; Shinobu Ohnuma; Hiroyuki Sasaki; Ryuichiro Sato; Hideaki Karasawa; Chikashi Shibata; Michiaki Unno; Iwao Sasaki; Hironobu Sasano
Journal:  Int J Cancer       Date:  2012-04-17       Impact factor: 7.396

6.  Report of cancer incidence and mortality in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou
Journal:  Ann Transl Med       Date:  2014-07

7.  Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.

Authors:  Johanna G H van Nes; Esther M de Kruijf; Hein Putter; Dana Faratian; Alison Munro; Fiona Campbell; Vincent T H B M Smit; Gerrit-Jan Liefers; Peter J K Kuppen; Cornelis J H van de Velde; John M S Bartlett
Journal:  Breast Cancer Res Treat       Date:  2011-07-28       Impact factor: 4.872

8.  Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.

Authors:  K Engels; S K Knauer; D Metzler; C Simf; O Struschka; C Bier; W Mann; A F Kovács; R H Stauber
Journal:  J Pathol       Date:  2007-04       Impact factor: 7.996

9.  Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells.

Authors:  Toyoshi Endo; Kazuyasu Ohta; Tetsuro Kobayashi
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

10.  Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.

Authors:  Nyam-Osor Chimge; Sanjeev K Baniwal; Gillian H Little; Yi-bu Chen; Michael Kahn; Debu Tripathy; Zea Borok; Baruch Frenkel
Journal:  Breast Cancer Res       Date:  2011-12-09       Impact factor: 6.466

View more
  6 in total

1.  Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.

Authors:  Rinath Jeselsohn; MacIntosh Cornwell; Matthew Pun; Gilles Buchwalter; Mai Nguyen; Clyde Bango; Ying Huang; Yanan Kuang; Cloud Paweletz; Xiaoyong Fu; Agostina Nardone; Carmine De Angelis; Simone Detre; Andrew Dodson; Hisham Mohammed; Jason S Carroll; Michaela Bowden; Prakash Rao; Henry W Long; Fugen Li; Mitchell Dowsett; Rachel Schiff; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

Review 2.  Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.

Authors:  Anai N Kothari; Matthew L Arffa; Victor Chang; Robert H Blackwell; Wing-Kin Syn; Jiwang Zhang; Zhiyong Mi; Paul C Kuo
Journal:  J Clin Med       Date:  2016-03-23       Impact factor: 4.241

3.  Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Saber Imani; Hossein Hosseinifard; Jingliang Cheng; Chunli Wei; Junjiang Fu
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

4.  Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer.

Authors:  Jie Ge; Yue Yu; Fei Xin; Zheng-Jun Yang; Hong-Meng Zhao; Xin Wang; Zhong-Sheng Tong; Xu-Chen Cao
Journal:  Cancer Sci       Date:  2017-04-12       Impact factor: 6.716

5.  Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.

Authors:  Zhan Li; Songcheng Yin; Lei Zhang; Weiguang Liu; Bo Chen
Journal:  Oncotarget       Date:  2017-03-07

Review 6.  Targeting protein quality control pathways in breast cancer.

Authors:  Sara Sannino; Jeffrey L Brodsky
Journal:  BMC Biol       Date:  2017-11-16       Impact factor: 7.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.